博文

The first targeted drug of cholangiocarcinoma, peimitinib, has both efficacy and safety -- The final results of FIGHT-202

日期：
0

Liver cancer screening in patients with liver cirrhosis can improve the early diagnosis, early treatment and survival rate

日期：
0

The efficacy and safety of double immunity combined STRIDE regimen in unresectable hepatocellular carcinoma

日期：
0

Three years of neglect lit up the light of clinical diagnosis and treatment of liver cancer

日期：
0

ILCA Keynote Report | Twenty Years of Progress -- Application and Prospect of Yttrium 90 Selective Internal Radiotherapy for Liver Cancer

日期：
0